Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Harris Todd Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2023 4 Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 7,927 shares @ $16.0048, valued at $126.9k
Sold 12,773 shares @ $16.1275, valued at $206k
Exercised 7,927 options to buy @ $2.25, valued at $17.8k
Exercised 12,773 options to buy @ $2.25, valued at $28.7k
04/05/2023 4 Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 2,000 shares @ $16.126, valued at $32.3k
Exercised 2,000 options to buy @ $2.25, valued at $4.5k
03/31/2023 4 Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 1,420 shares @ $16.1835, valued at $23k
Sold 2,407 shares @ $16.0166, valued at $38.6k
Sold 500 shares @ $16.046, valued at $8k
Exercised 1,420 options to buy @ $2.25, valued at $3.2k
Exercised 2,407 options to buy @ $2.25, valued at $5.4k
Exercised 500 options to buy @ $2.25, valued at $1.1k
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/23/2023 4 Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Sold 12,393 shares @ $16, valued at $198.3k
Sold 4,043 shares @ $16, valued at $64.7k
Sold 2,800 shares @ $16, valued at $44.8k
Exercised 12,393 options to buy @ $2.25, valued at $27.9k
Exercised 4,043 options to buy @ $2.25, valued at $9.1k
Exercised 2,800 options to buy @ $2.25, valued at $6.3k
03/17/2023 4 Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Granted 1,808 shares @ $6.579, valued at $11.9k
09/08/2022 4 Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Granted 3,125 shares @ $8.5255, valued at $26.6k
Granted 270,000 options to buy @ $7.14, valued at $1.9M
11/04/2021 4 Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Granted 215,038 options to buy @ $24.15, valued at $5.2M
Granted 25,884 options to buy @ $24.15, valued at $625.1k
09/17/2021 4 Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.
Txns: Converted 34,007 shares @ $0
Converted 13,093 preferred shares @ $0
06/03/2019 4 Harris Todd (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $1.22, valued at $30.5k
05/02/2018 4 Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns: Sold 100 shares @ $20, valued at $2k
04/25/2018 4 Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns: Sold 525 shares @ $20, valued at $10.5k
Sold 150 shares @ $20, valued at $3k
Sold 300 shares @ $20, valued at $6k
04/19/2018 4 Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns: Sold 2,201 shares @ $20, valued at $44k
Sold 15,810 shares @ $20.0885, valued at $317.6k
04/12/2018 4 Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns: Sold 3,779 shares @ $20.0161, valued at $75.6k
04/09/2018 4 Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns: Sold 5,386 shares @ $20.001, valued at $107.7k
Sold 2,824 shares @ $20, valued at $56.5k
03/20/2018 4 Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns: Sold 5,876 shares @ $20, valued at $117.5k
03/14/2018 4 Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns: Sold 3,452 shares @ $20.1127, valued at $69.4k
03/09/2018 4 Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns: Sold 3,704 shares @ $20, valued at $74.1k
Sold 14,530 shares @ $20.0342, valued at $291.1k
Sold 2,438 shares @ $20.0099, valued at $48.8k
07/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy